These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16880650)

  • 1. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules III. Effects of the dissolution condition on the release process.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1091-6. PubMed ID: 16880650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1569-73. PubMed ID: 17978513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules V. Release properties of ethylcellulose layered matrix granules.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):525-9. PubMed ID: 18379102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules II. effects of the binder solution on the release process.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):298-302. PubMed ID: 14993750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules.
    Fukui A; Fujii R; Yonezawa Y; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1439-42. PubMed ID: 12419906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.
    Sevgi F; Ozyazici M; Güneri T
    J Microencapsul; 1994; 11(3):327-34. PubMed ID: 8064556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.
    Agrawal AM; Neau SH; Bonate PL
    AAPS PharmSci; 2003; 5(2):E13. PubMed ID: 12866940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method.
    Ikegami K; Tagawa K; Kobayashi M; Osawa T
    Int J Pharm; 2003 Jun; 258(1-2):31-43. PubMed ID: 12753751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. I. Formulation and dissolution characteristics.
    Ohmori S; Makino T
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):673-7. PubMed ID: 10823705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusion.
    Verhoeven E; De Beer TR; Van den Mooter G; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):312-9. PubMed ID: 18036793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a sustained release preparation containing phenylpropanolamine hydrochloride.
    Yamakawa I; Shimomura M; Hattori T; Watanabe S; Tsutsumi J; Shinoda A; Miyake Y
    J Pharmacobiodyn; 1986 Dec; 9(12):947-52. PubMed ID: 3572716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
    Ohara T; Kitamura S; Kitagawa T; Terada K
    Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline.
    Afrasiabi Garekani H; Faghihnia Torshizi M; Sadeghi F
    Drug Dev Ind Pharm; 2015; 41(10):1655-60. PubMed ID: 25402967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time predictions of drug release and end point detection of a coating operation by in-line near infrared measurements.
    Gendre C; Boiret M; Genty M; Chaminade P; Pean JM
    Int J Pharm; 2011 Dec; 421(2):237-43. PubMed ID: 21983094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
    Song QL; Li P; Li YM
    Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.